Abstract
In order to further understanding of how different isolates of Burkholderia cepacia complex persist, spread and cause disease, B. cepacia-complex isolates from 60 patients attending the Cystic Fibrosis Centre of Verona, Italy, between 1997 and 2002 were analyzed. Strains were examined for species, presence of putative epidemic and virulence markers (i.e., cblA and the B. cepacia epidemic-strain marker [BCESM]), genetic relatedness and antibiotic susceptibility. Forty-five percent of patients were infected with B. cenocepacia recA subgroup B, 28% with B. cenocepacia recA subgroup A, 5% with B. multivorans and 5% with B. cepacia. No isolate carried cblA but 35% of B. cenocepacia and one of B. cepacia carried the BCESM transmissibility marker. Pulsed-field gel electrophoresis (PFGE) identified 40 types; 22 of these corresponded to sporadic isolates and 18 to clusters of identical or genetically related strains. Piperacillin, ceftazidime and piperacillin-tazobactam were the most active antibiotics (43.3, 31.1 and 35.5% of resistance, respectively). These results confirm the prevalence of B. cenocepacia in cystic fibrosis patients with rapid clinical deterioration and in those with stable cases of infection. The rates of multiple-so...Continue Reading
References
Sep 1, 1995·Journal of Clinical Microbiology·F C TenoverB Swaminathan
Mar 1, 1996·Journal of Medical Microbiology·T L PittD M Livermore
Dec 1, 1996·Journal of Medical Microbiology·J R GovanP Vandamme
Apr 1, 1997·Journal of Clinical Microbiology·E MahenthiralingamD P Speert
Feb 3, 2000·Journal of Clinical Microbiology·E MahenthiralingamP Vandamme
May 2, 2000·Journal of Clinical Microbiology·F E ClodeT L Pitt
Sep 2, 2000·Journal of Clinical Microbiology·E MahenthiralingamP Vandamme
Jul 4, 2001·American Journal of Respiratory and Critical Care Medicine·J J LiPumaE Mahenthiralingam
Mar 7, 2002·Journal of Clinical Microbiology·Annamaria BevivinoGraziana Manno
Mar 19, 2002·Emerging Infectious Diseases·David P SpeertEshwar Mahenthiralingam
Apr 26, 2002·Journal of Applied Microbiology·D CrowleyS Fanning
Aug 31, 2002·Journal of Clinical Microbiology·Tom CoenyeJohn J LiPuma
Jun 7, 2003·Journal of Clinical Microbiology·Tom CoenyeEshwar Mahenthiralingam
Jul 29, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T J KiddC Coulter
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott A BernhardtJohn J LiPuma
Sep 6, 2003·Journal of Clinical Microbiology·Mónica V CunhaIsabel Sá-Correia
Sep 23, 2003·Research in Microbiology·Andrea PetruccaMauro Nicoletti
Jun 9, 2004·Journal of Medical Microbiology·Andrew McDowellJ Stuart Elborn
Citations
Jul 5, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J H LeitãoI Sá-Correia
Aug 3, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M J Medina-PascualJ A Saéz-Nieto
Oct 21, 2006·Current Opinion in Pulmonary Medicine·Theodore G LiouBarbara C Cahill
May 11, 2011·BMC Structural Biology·Rachel E MorganWilliam N Hunter
Jan 23, 2010·Annals of Clinical Microbiology and Antimicrobials·William R SchwanRonald McKelvey
Jun 27, 2013·PloS One·Laura A NovotnyLauren O Bakaletz
Jul 12, 2011·Biotechnology Advances·Maria Cristiana PapaleoRenato Fani
Sep 30, 2010·Journal of Applied Microbiology·L GolshahiW H Finlay
Jan 16, 2007·Chemistry : a European Journal·Alba SilipoMichelangelo Parrilli
Nov 13, 2019·Antimicrobial Agents and Chemotherapy·Mojgan Sabet, David C Griffith
Dec 3, 2008·Microbiology·Julie Lamothe, Miguel A Valvano
Mar 17, 2015·Expert Review of Anti-infective Therapy·Vikas GautamAmit Agarwal
Oct 2, 2017·Medical Microbiology and Immunology·Priscila DentiniJosé Dirceu Ribeiro